Clinical Trials Logo

Clinical Trial Summary

This is a pilot study to test the feasibility of implementing a strict classic ketogenic diet among a population of children with recurrent or progressive and refractory brain tumors. Eligible participants will be admitted to the neurosciences floor for 5 days to begin the ketogenic diet either orally, by gastrostomy tube or via nasogastric tube. During the inpatient stay, they will be extensively educated on the diet restrictions and rules. Participants will then continue on the diet at home returning about 17 times over the next 12 months. Daily logs will be kept tracking diet changes, bowel movements and urine ketones. Blood will be collected during the inpatient stay and at all visits for both standard clinical care and research testing.


Clinical Trial Description

Primary Objective is to determine the feasibility (safety and tolerability) of a strict classic ketogenic diet among a population of children with recurrent or progressive and refractory brain tumors. Secondary Objectives are: (1) to determine the objective response rate (complete response + partial response) to a strict classic ketogenic diet among children with recurrent or progressive and refractory brain tumor; (2) to estimate the time interval to tumor progression (Progression-Free Survival), time to treatment failure (Event-Free Survival), and time to death (Overall Survival) after initiation of a strict classic ketogenic diet among a group of pediatric patients with recurrent or progressive and refractory brain tumors; and (3) to describe and characterize tolerability and toxicities from a strict classic ketogenic diet among children with recurrent or progressive and refractory brain tumors. Exploratory Objective: Identify biomarker correlates, including MR spectroscopy and metabolites of tumor response to a strict classic ketogenic diet. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03955068
Study type Interventional
Source University of Texas Southwestern Medical Center
Contact
Status Withdrawn
Phase N/A
Start date July 2024
Completion date January 2027

See also
  Status Clinical Trial Phase
Completed NCT04309214 - Market Research - Acceptability Study for New MCT Fat Products N/A
Completed NCT04309149 - Market Research - Acceptability Study for a Range of MCT Products N/A
Not yet recruiting NCT06106139 - Ketogenic Diet Improves Thrombocytopenia in Cancer Patients Phase 1/Phase 2
Terminated NCT05350657 - Ketogenic Dietary Patterns in Young Adults and Kidney Health N/A
Terminated NCT05291767 - High Fat Meal and Postprandial TG Levels With and Without Exercise Intervention N/A
Completed NCT00476125 - Effects of Dietary Manipulation on Metabolism in Healthy Adults N/A
Active, not recruiting NCT05279118 - Ketogenic Diet vs ACTH for the Treatment of Children With West Syndrome Phase 2/Phase 3
Completed NCT05697887 - Feasibility, Tolerability and Efficacy of the Ketogenic Diet in Children With Drug-resistant Epilepsy in South Vietnam N/A
Completed NCT06449287 - Impact of Exogenous Ketones on Indices of Keto-Adaptation in Obese Subjects on Weight Reducing Diets. N/A
Completed NCT06255873 - Effects of L-Carnitine on Gastric Emptying in Children With Drug Resistant Epilepsy on Ketogenic Diet N/A
Completed NCT04165707 - A Weight Loss RCT Comparing Keyto vs Weight Watchers N/A
Completed NCT06432231 - Effects of Low Glycemic Index Diet in Children With Drug-resistant Epilepsy N/A